Início > > Resultado da busca

Resultados: 2

Clinical outcomes in patients with high bleeding risk and bifurcations after percutaneous coronary intervention with resolute onyx and 1-month dual antiplatelet therapy

Kirtane, Ajay; Kandzari, David; Latib, Azeem; Kedhi, Elvin Belgium; Mehran, Roxana; Pric, Matthew; Simon, Daniel; Abizaid, Alexandre; Parke, Maria; Lung, Te-Hsin; Windecker, Stephan; Stone, Gregg.
J. Am. Coll. Cardiol; 77 (14 suppl. s), 2021
BACKGROUND The optimal duration of dual antiplatelet therapy (DAPT) in patients with high bleeding risk (HBR) undergoing percu taneous coronary intervention (PCI) varies based on individual clinical and lesion characteristics. It is unknown whether patients with HBR and bifurcation lesions can be safely ...
Hemorragia/complicações, Inibidores da Agregação Plaquetária
Texto completo

Ischemic and bleeding outcomes in patients with versus without atrial fibrillation: analysis from the onyx one month dapt program

Pasupati, Sanjeevan; Latib, Azeem; Kedhi, Elvin; Kirtane, Ajay; Kandzari, David; Mehran, Roxana; Price, Matthew; Simon, Daniel; Abizaid, Alexandre; Worthley, Stephen G; Zaman, Azfar; Parke, Maria; Lung, Te-Hsin; Windecker, Stephan; Stone, Gregg.
J. Am. Coll. Cardiol; 76 (17 suppl. b), 2020
BACKGROUND The Onyx ONE and Onyx ONE CLEAR studies demonstrated favorable safety and effectiveness in patients at high bleeding risk (HBR) who were event-free 1 month following Resolute Onyx zotarolimus-eluting stent (ZES) implantation and were then treated with single antiplatelet therapy (SAPT) through...
Fibrilação Atrial, Hemorragia/complicações, Stents Farmacológicos
Texto completo